132 related articles for article (PubMed ID: 33847629)
21. Evaluation of the analytical and clinical performances of time-resolved fluoroimmunoassay for detecting carcinoma antigen 50.
Xie M; Huang H; Hang J; Dong Z; Xiao D; Xu P; Zhu C; Xu W
J Immunoassay Immunochem; 2015; 36(3):265-83. PubMed ID: 24979296
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
Nilsson O; Johansson C; Glimelius B; Persson B; Nørgaard-Pedersen B; Andrén-Sandberg A; Lindholm L
Br J Cancer; 1992 Feb; 65(2):215-21. PubMed ID: 1739620
[TBL] [Abstract][Full Text] [Related]
23. [Clinical value of carbohydrate antigen 50 and carbohydrate antigen 242 in the diagnosis of colorectal carcinoma].
Huang CW; Bai L
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1116-8. PubMed ID: 12480590
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
Kawa S; Tokoo M; Hasebe O; Hayashi K; Imai H; Oguchi H; Kiyosawa K; Furuta S; Homma T
Br J Cancer; 1994 Sep; 70(3):481-6. PubMed ID: 8080734
[TBL] [Abstract][Full Text] [Related]
25. CA242 as a biomarker for pancreatic cancer and other diseases.
Dou H; Sun G; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():229-239. PubMed ID: 30905452
[TBL] [Abstract][Full Text] [Related]
26. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.
Jiang JT; Wu CP; Deng HF; Lu MY; Wu J; Zhang HY; Sun WH; Ji M
World J Gastroenterol; 2004 Jun; 10(11):1675-7. PubMed ID: 15162550
[TBL] [Abstract][Full Text] [Related]
27. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
[TBL] [Abstract][Full Text] [Related]
28. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
Gui JC; Yan WL; Liu XD
Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
[TBL] [Abstract][Full Text] [Related]
29. Performance evaluation of a chemiluminescence microparticle immunoassay for CK-MB.
Lin ZY; Fang YZ; Jin HW; Lin HY; Dai Z; Luo Q; Li HW; Lin YL; Huang SZ; Gao L; Xu FH; Zhang ZY
J Clin Lab Anal; 2018 Jul; 32(6):e22426. PubMed ID: 29604095
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of time-resolved fluorometric immunoassay of CA 50].
Hara K; Mitsuhashi F; Sakawaki T; Ohkura H
Rinsho Byori; 1989 Jul; 37(7):789-94. PubMed ID: 2691736
[TBL] [Abstract][Full Text] [Related]
31. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
Zhao XW; Jiang B; Han CZ; Jing JX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
[TBL] [Abstract][Full Text] [Related]
32. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
Fisken J; Leonard RC; Roulston JE
Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
[TBL] [Abstract][Full Text] [Related]
33. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
34. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
35. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
Wu J; Yu H; Shao Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
[TBL] [Abstract][Full Text] [Related]
36. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
Rao H; Wu H; Huang Q; Yu Z; Zhong Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
[TBL] [Abstract][Full Text] [Related]
37. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and evaluation of a time-resolved fluoroimmunoassay kit for CA50 determination].
Hang JF; Wu YS; Xu WW; Yu WH; Huang Y; Li M
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):189-92. PubMed ID: 17649634
[TBL] [Abstract][Full Text] [Related]
39. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
Su J; Wang Y; Shao H; You X; Li S
World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
[TBL] [Abstract][Full Text] [Related]
40. Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.
Li X; Li S; Zhang Z; Huang D
PeerJ; 2022; 10():e13488. PubMed ID: 35611170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
